Saturday 4 April 2009

Zero Flow- diagnostics in the fields of both genomic and proteomic science

In March 2007, Mediwatch filed a patent for an innovative, new technology - Lateral flow assay and apparatus. We have called this technology "Zero Flow".

We believe that Zero Flow (patent pending) has exciting possibilities for diagnostics in the fields of both genomic and proteomic science.

Early in January 2009 a senior molecular research scientist, Dr. Marcus Harrison, joined our staff to underpin the development of new tests with molecular markers and to assist in developing the Zero Flow (patent pending) technology platform.

We are genuinely excited about the future possibilities this may hold for Mediwatch.

No comments:

Post a Comment